Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal

Henning F Kramer1, Carol A Witczak, Nobuharu Fujii

  • 1Section Head, Metabolism, Joslin Diabetes Center, One Joslin Pl., Boston, MA 02215, USA.

Diabetes
|June 29, 2006
PubMed

Insights

Insulin and muscle contraction stimulate glucose uptake via distinct pathways. Both pathways converge on AS160 phosphorylation, involving Akt and AMPK signaling, but contraction

Area of Science:

  • * Molecular biology
  • * Cell signaling
  • * Exercise physiology

Background:

  • * Glucose transporter type 4 (GLUT4) translocation to the plasma membrane is crucial for glucose uptake in skeletal muscle.
  • * Insulin and muscle contraction are major stimulators of GLUT4 translocation, but their signaling pathways differ.
  • * Akt substrate of 160 kDa (AS160) is a key regulator in insulin-stimulated GLUT4 trafficking.

Purpose of the Study:

  • * To investigate the distinct and convergent signaling mechanisms regulating AS160 phosphorylation by insulin, contraction, and AICAR (an AMPK activator).
  • * To elucidate the roles of Akt and AMP-activated protein kinase (AMPK) in mediating these responses in mouse skeletal muscle.

Main Methods:

  • * In vivo, in vitro, and in situ experiments using wild-type, Akt2 knockout, and AMPK alpha2-inactive transgenic mice.
  • * Treatment with wortmannin (an Akt inhibitor) and AICAR (an AMPK activator).
  • * Measurement of AS160 phosphorylation levels under various stimulation conditions.

Main Results:

  • * Insulin-stimulated AS160 phosphorylation is dependent on Akt2 and inhibited by wortmannin.
  • * Contraction-stimulated AS160 phosphorylation is only partially affected by wortmannin and Akt2 knockout, suggesting alternative pathways.
  • * AICAR-stimulated AS160 phosphorylation is mediated by AMPK alpha2, while contraction-stimulated phosphorylation involves both Akt and AMPK alpha2, with neither being solely indispensable.

Conclusions:

  • * AS160 serves as a convergence point for insulin, contraction, and AICAR signaling pathways in skeletal muscle.
  • * Akt and AMPK alpha2 are essential for insulin and AICAR-induced AS160 phosphorylation, respectively.
  • * Contraction-induced AS160 phosphorylation involves complex regulation by both Akt and AMPK, with neither kinase fully accounting for the effect.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...